SRx Health Solutions, Inc. Financial Summary

Quick Answer

SRx Health Solutions, Inc. reported Total Revenue of $6.53 million for fiscal year 2025.

SRx Health Solutions, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $6.53M
+226.7%
$2.00M
-94.8%
$38.59M
-29.4%
$54.66M
+18.8%
$46.01M
+8.0%
$42.59M
+173.4%
Revenue (ASC 606) $6.53M
+226.7%
$2.00M
-94.8%
$38.59M
-29.4%
$54.66M
+18.8%
$46.01M
+8.0%
$42.59M
+173.4%
Net Income -$45.01M
-4.5%
-$43.05M
-89.1%
-$22.77M
+42.1%
-$39.32M
-1260.8%
$3.39M
+105.7%
-$59.34M
+67.8%
Diluted EPS -$2.13
-9.2%
-$1.95
+94.0%
-$32.29
+45.2%
-$58.93
-42192.9%
$0.14
+101.9%
-$7.26
Total Assets $8.40M
-75.1%
$33.76M
+101.7%
$16.74M
-56.7%
$38.68M
-48.2%
$74.66M
+45.7%
$51.25M
-4.3%
Cash and Equivalents $1.31M
+1134.9%
$106.0K
-97.6%
$4.46M
+40.4%
$3.17M
-85.4%
$21.73M
+453.5%
$3.93M
+66.3%
Long-Term Debt $696.0K
Stockholders Equity $407.0K
+100.7%
-$55.12M
-63.2%
-$33.78M
-256.9%
$21.53M
-62.8%
$57.88M
+305.9%
-$28.10M
-297.4%
Operating Income -$11.41M
-91.2%
-$5.97M
+71.8%
-$21.18M
+45.4%
-$38.78M
-124.5%
-$17.28M
+36.8%
-$27.32M
+24.8%
Gross Profit $1.53M
-88.3%
$12.99M
+10.1%
$11.80M
-22.7%
$15.26M
-0.7%
$15.37M
-4.6%
$16.11M
+174.8%
Shares Outstanding 24.92M
+10.8%
22.50M
+2985.8%
729,026
+9.0%
668,869
-97.7%
29.15M
+236.9%
8.65M
-82.0%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2025 $2.81M -75.5%
Revenue (ASC 606) December 31, 2025 $2.81M -75.5%
Net Income December 31, 2025 -$8.61M -116.3% +43.1%
Diluted EPS December 31, 2025 -$0.26 -52.9% +64.9%
Total Assets December 31, 2025 $27.05M +71.2% +222.0%
Cash and Equivalents December 31, 2025 $13.06M +326.0% +897.7%
Long-Term Debt June 30, 2025 $1.90M +173.4%
Stockholders Equity December 31, 2025 $3.52M +105.5% +765.8%
Operating Income December 31, 2025 -$3.79M +78.2%
Gross Profit December 31, 2025 $1.05M -69.2%
Shares Outstanding December 31, 2025 98.76M +5296.4% +296.4%
  • SRx Health Solutions, Inc. reported Total Revenue of $6.53 million for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -81.3% in Total Revenue compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Revenue (ASC 606) of $6.53 million for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -81.3% in Revenue (ASC 606) compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Net Income of -$45.01 million for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -26689.3% in Net Income compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Diluted EPS of $2.13 per share (loss) for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -2030.0% in Diluted EPS compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Total Assets of $8.40 million for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -46.8% in Total Assets compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Cash and Equivalents of $1.31 million for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -57.3% in Cash and Equivalents compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Long-Term Debt of $696.0 thousand for fiscal year 2024.
  • SRx Health Solutions, Inc. reported Stockholders Equity of $407.0 thousand for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -95.3% in Stockholders Equity compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Operating Income of -$11.41 million for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -91.2% in Operating Income compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Gross Profit of $1.53 million for fiscal year 2025.
  • SRx Health Solutions, Inc. showed a decrease of -88.3% in Gross Profit compared to the prior fiscal year.
  • SRx Health Solutions, Inc. reported Shares Outstanding of 24.92 million shares for fiscal year 2025.
  • SRx Health Solutions, Inc. showed an increase of +1261.4% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment